ZATTARIN, EMMA
 Distribuzione geografica
Continente #
NA - Nord America 233
AS - Asia 70
EU - Europa 41
Continente sconosciuto - Info sul continente non disponibili 7
SA - Sud America 5
AF - Africa 3
Totale 359
Nazione #
US - Stati Uniti d'America 221
SG - Singapore 34
IT - Italia 29
CN - Cina 13
VN - Vietnam 8
HK - Hong Kong 6
CA - Canada 4
FI - Finlandia 3
GB - Regno Unito 3
KR - Corea 3
MX - Messico 3
BD - Bangladesh 2
CW - ???statistics.table.value.countryCode.CW??? 2
FR - Francia 2
SC - Seychelles 2
SV - El Salvador 2
AR - Argentina 1
BR - Brasile 1
BS - Bahamas 1
CI - Costa d'Avorio 1
CL - Cile 1
DE - Germania 1
GP - Guadalupe 1
ID - Indonesia 1
IL - Israele 1
IN - India 1
MK - Macedonia 1
SA - Arabia Saudita 1
SI - Slovenia 1
TT - Trinidad e Tobago 1
UA - Ucraina 1
UY - Uruguay 1
VE - Venezuela 1
Totale 354
Città #
San Jose 35
Singapore 21
Ashburn 20
Council Bluffs 18
Los Angeles 8
Beijing 6
Hong Kong 6
Ho Chi Minh City 5
Modena 5
New York 5
Boardman 4
Dallas 4
Santa Clara 4
Chicago 3
Lappeenranta 3
Rome 3
Seoul 3
Toronto 3
Cleveland 2
Concord 2
Denver 2
Lansdowne 2
Milan 2
Naples 2
Ocala 2
Phoenix 2
Savannah 2
Willemstad 2
Abidjan 1
Albuquerque 1
Brooklyn 1
Cagliari 1
Chalmette 1
Clearwater 1
Commack 1
Correggio 1
Dothan 1
Dubuque 1
El Segundo 1
Evansville 1
Frankfurt am Main 1
Genoa 1
Gia Nghĩa 1
Gourbeyre 1
Great Neck 1
Hanoi 1
Heber 1
Jakarta 1
Jamestown 1
Jeddah 1
Kyiv 1
La Plata 1
Las Vegas 1
Lauterbourg 1
Ljubljana 1
Manchester 1
Marseille 1
Martinsburg 1
Mesa 1
Mexico City 1
Minneapolis 1
Montevideo 1
Nassau 1
Ocoee 1
Orta Nova 1
Palermo 1
Perugia 1
Peterborough 1
Philadelphia 1
Pompano Beach 1
Port of Spain 1
Pueblo 1
Rancagua 1
Riverview 1
Rubio 1
Sacramento 1
Salem 1
San Donà di Piave 1
San Miguel 1
San Salvador 1
Savignano sul Panaro 1
Skopje 1
Tampa 1
The Bronx 1
Tlajomulco de Zúñiga 1
Tláhuac 1
Topeka 1
Vũng Tàu 1
Xanxerê 1
Totale 237
Nome #
Impaired glucose tolerance in women with BRCA1 versus BRCA2 pathogenic or likely pathogenic variants: Results from a prospective cohort study 130
Time to next treatment to evaluate the therapeutic sequence after first- or second-line CDK4/6 inhibitors of hormone receptor-positive, HER2-negative advanced breast cancer in Italy: a retrospective/prospective observational trial GOIRC-04-2019 86
Impact of Ethnicity on Breast Cancer Outcome: A Systematic Review and Meta-Analysis of Randomized Phase III Trials of the Last Decade. 79
Real-world effectiveness of PARP inhibitors after CDK4/6 inhibitor therapy in BRCA-mutated HR-positive/HER2-negative advanced breast cancer 64
Totale 359
Categoria #
all - tutte 1.689
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.689


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2025/2026134 0 0 0 0 0 15 20 19 30 22 19 9
2026/2027225 24 39 98 51 13 0 0 0 0 0 0 0
Totale 359